Table 1.
Comparison of clinicopathological profiles between low and high BCAP31 expression in BC patients. (n = 186 patients)*
| BCAP31 expression | |||||
|---|---|---|---|---|---|
| High (N = 87) | Low (N = 99) | ||||
| Clinical Valuable | No. of patients |
% | No. of patients |
% | p Value |
| Age (years), median (range)a | 50 (33-76) | 51 (32-80) | 0.9849 | ||
| Age, yearsb | |||||
| ≤50 | 44 | 50.57 | 49 | 49.49 | 0.8832 |
| >50 | 43 | 49.43 | 50 | 50.51 | |
| Gradeb | |||||
| High | 2 | 2.30 | 2 | 2.02 | 0.8607 |
| Intermediate | 54 | 62.07 | 58 | 58.59 | |
| Low | 20 | 22.99 | 22 | 22.22 | |
| Unknown | 11 | 12.64 | 17 | 17.17 | |
| pTNM stageb# | |||||
| I | 19 | 21.84 | 39 | 37.37 | 0.0756 |
| II | 50 | 57.47 | 48 | 48.48 | |
| III | 18 | 20.69 | 13 | 13.13 | |
| NA | 0 | 0.00 | 1 | 0.54 | |
| Tumor size (cm)b | |||||
| ≤2 | 36 | 41.38 | 49 | 48.48 | 0.3698 |
| 2~5 | 46 | 52.87 | 43 | 43.43 | |
| >5 | 5 | 5.75 | 6 | 6.06 | |
| Unknown | 0 | 0.00 | 2 | 2.02 | |
| LN statusb | |||||
| Negative | 50 | 57.47 | 64 | 64.65 | 0.3534 |
| Positive | 37 | 42.53 | 34 | 34.34 | |
| Unknown | 0 | 0.00 | 1 | 1.01 | |
| Molecular subtypeb | |||||
| Luminal A | 11 | 12.64 | 30 | 30.30 | 0.0000 |
| Luminal B | 14 | 16.09 | 29 | 29.29 | |
| HER2+ | 5 | 5.75 | 20 | 20.20 | |
| TNBC | 57 | 65.52 | 20 | 20.20 | |
* LN, lymph node; TNBC, triple negative breast cancer; pTNM, pathologic tumor, lymph node, metastasis classification.
# pTNM stage IV was not included in this cohort of patients.
a Student's t test.
b P values based on Pearson's Chi-square test for categorical (counts, percentage) variables.